Work

Uniformly positive (>80%) HER2 expression maximizes sensitivity and specificity for prediction of response to trastuzumab in CALGB 9840.

Year: 2009

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/0008-5472.sabcs-6046

Authors: DL Rimm, G Broadwater, P Friedman, D Berry, A Seidman, C Hudis, E Winer, L Harris, A Thor

Institutions: Yale University, Duke Medical Center, The University of Texas MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, University of Colorado Denver

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2037392150

Cites:

Cited by: 1

Related to: 10